Role of fibulin-3 in lung cancer: In vivo and in vitro analyses

Oncology Reports

Volumn 31, Issue 1, 2014, Pages 79-86

  Xu, Shun ^a   Yang, Yong ^b   Sun, Yan Bin ^a   Wang, Hao You ^a   Sun, Chang Bo ^a   Zhang, Xin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Sujiatun Central Hospital   (China)

Author keywords

Fibulin 3; Lung cancer; Methylation; Prognosis; Survival analysis

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; FIBULIN; FIBULIN 3; GELATINASE A; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN A549; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; ENZYME REGULATION; EXPRESSION VECTOR; FEMALE; FIBULIN 3 BLOOD LEVEL; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG CARCINOGENESIS; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL RATE;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DNA METHYLATION; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASTIC CELLS, CIRCULATING; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SURVIVAL RATE; TRANSFECTION; WOUND HEALING;

EID: 84891944991     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2799     Document Type: Article

References (25)

1. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Lam WK, White NW and Chan-Yeung MM: Lung cancer epidemiology and risk factors in Asia and Africa. Int J Tuberc Lung Dis 8: 1045-1057, 2004.
3. Kobayashi N, Kostka G, Garbe JH, et al: A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization. J Biol Chem 282: 11805-11816, 2007.
4. Timpl R, Sasaki T, Kostka G and Ghu ML: Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 4: 479-489, 2003.
5. Pupa SM, Giuffré S, Castiglioni F, et al: Regulation of breast cancer response to chemotherapy by fibulin-1. Cancer Res 67: 4271-4277, 2007.
6. Yi CH, Smith DJ, West WW and Hollingsworth MA: Loss of fibulin-2 expression is associated with breast cancer progression. Am J Pathol 170: 1535-1545, 2007.
7. Albig AR and Schiemann WP: Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. DNA Cell Biol 23: 367-379, 2004.
8. Zhang Y and Marmorstein LY: Focus on molecules: fibulin-3 (EFEMP1). Exp Eye Res 90: 374-375, 2010.
9. Sadr-Nabavi A, Ramser J, Volkmann J, et al: Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. Int J Cancer 124: 1727-1735, 2009.
10. Yue W, Dacic S, Sun Q, et al: Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation. Clin Cancer Res 13: 4336-4344, 2007.
11. Nomoto S, Kanda M, Okamura Y, et al: Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Ann Surg Oncol 17: 923-932, 2010.
12. Lecka-Czernik B, Lumpkin CK Jr and Goldstein S: An overexpressed gene transcript in senescent and quiescent human fibroblasts encoding a novel protein in the epidermal growth factor-like repeat family stimulates DNA synthesis. Mol Cell Biol 15: 120-128, 1995.
13. Hata K, Dhar DK, Watanabe Y, et al: Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer. Eur J Cancer 43: 1452-1459, 2007.
14. Albig AR, Neil JR and Schiemann WP: Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res 66: 2621-2629, 2006.
15. Hu B, Thirtamara-Rajamani KK, Sim H and Viapiano MS: Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion. Mol Cancer Res 7: 1756-1770, 2009.
16. Seeliger H, Camaj P, Ischenko I, et al: EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarci noma. Mol Cancer Res 7: 189-198, 2009.
17. Wang R, Zhang YW and Chen LB: Aberrant promoter methylation of FBLN-3 gene and clinicopathological significance in non-small cell lung carcinoma. Lung Cancer 69: 239-244, 2010.
18. Kim EJ, Lee SY, Woo MK, et al: Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulation. Int J Oncol 40: 402-408, 2012.
19. Tong JD, Jiao NL, Wang YX, Zhang YW and Han F: Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis. Neoplasma 58: 441-448, 2011.
20. Cristofanilli M, Hayes DF, Budd GT, et al: Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23: 1420-1430, 2005.
21. Osta WA, Chen Y, Mikhitarian K, et al: EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 64: 5818-5824, 2004.
22. Allard WJ, Matera J, Miller MC, et al: Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10: 6897-6904, 2004.
23. Pass HI, Levin SM, Harbut MR, et al: Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med 367: 1417-1427, 2012.
24. Hsu HH, Liu CJ, Shen CY, et al: p38α MAPK mediates 17β-estradiol inhibition of MMP-2 and -9 expression and cell migration in human lovo colon cancer cells. J Cell Physiol 227: 3648-3660, 2012.
25. Kumar B, Koul S, Petersen J, et al: p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity. Cancer Res 70: 832-841, 2010.